Astrazeneca Income Statement (2009-2026) | AZN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	8.22B	9.87B	12.01B	10.98B	10.77B	10.59B	10.80B	10.88B	11.42B	11.49B	12.02B	12.68B	12.94B	13.56B	14.89B	13.59B	14.46B	15.19B	15.50B	15.29B
Cost of Revenue (Quarter)	2.19B	3.76B	4.62B	3.51B	3.00B	2.98B	2.90B	1.91B	1.96B	2.10B	2.31B	2.22B	2.18B	3.08B	2.73B	2.24B	2.47B	2.80B	3.12B	2.68B
Gross Profit (Quarter)	6.03B	6.11B	7.39B	7.88B	7.77B	8.00B	8.31B	8.97B	9.46B	9.40B	9.72B	10.46B	10.76B	10.48B	12.17B	11.35B	11.98B	12.39B	12.38B	12.61B
Operating items
Amortization - Intangibles (Quarter)
Research & Development (Quarter)	-1.83B	-3.61B	-2.58B	-2.13B	-2.55B	-2.46B	-2.62B	-2.61B	-2.67B	-2.58B	-3.07B	-2.78B	-3.01B	-3.12B	-4.68B	-3.16B	-3.55B	-3.66B	-3.86B	-3.49B
Selling, General & Administrative (Quarter)	-3.10B	-4.09B	-5.12B	-4.84B	-4.68B	-4.28B	-4.62B	-4.06B	-4.99B	-4.80B	-5.37B	-4.50B	-4.93B	-5.14B	-5.41B	-4.49B	-4.86B	-5.08B	-5.49B	-4.92B
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)	0.13B	0.04B	0.15B	0.10B	0.12B	0.11B	0.19B	0.38B	0.78B	0.07B	0.11B	0.07B	0.06B	0.03B	0.10B	0.11B	0.08B	0.09B	0.10B	0.19B
Operating Expenses (Quarter)	-4.93B	-7.70B	-7.70B	-7.10B	-7.23B	-6.74B	-7.25B	-6.67B	-7.65B	-7.38B	-8.44B	-7.28B	-7.94B	-8.26B	-10.09B	-7.65B	-8.41B	-8.75B	-9.35B	-8.41B
Operating Income (Quarter)	1.13B	-1.67B	-0.29B	0.88B	0.54B	1.25B	1.09B	2.55B	2.46B	1.95B	1.23B	3.12B	2.75B	2.11B	2.04B	3.67B	3.51B	3.58B	2.98B	4.25B
EBIT (Quarter)	1.13B	-1.67B	-0.29B	0.88B	0.54B	1.25B	1.09B	2.55B	2.46B	1.95B	1.23B	3.12B	2.75B	2.11B	2.04B	3.67B	3.51B	3.58B	2.98B	4.25B
Non-operating items
Interest & Investment Income (Quarter)	0.01B	0.01B	0.00B	0.02B	0.02B	0.01B	0.04B	0.08B	0.06B	0.10B	0.11B	0.11B	0.10B	0.18B	0.06B	0.08B	0.07B	0.09B	0.14B	0.07B
Non Operating Income (Quarter)		0.32B	0.34B	-0.32B	0.93B			0.29B	0.37B	-0.29B	-0.94B	0.30B	0.34B	-0.27B	0.36B	0.27B	0.37B	0.35B	0.35B	0.32B
Net income details
EBT (Quarter)	0.76B	-2.00B	-0.64B	0.55B	0.25B	0.92B	0.78B	2.26B	2.09B	1.65B	0.90B	2.80B	2.40B	1.83B	1.67B	3.40B	3.13B	3.24B	2.63B	3.91B
Profit After Tax (Quarter)	0.55B	-1.65B	-0.35B	0.39B	0.36B	1.64B	0.90B	1.80B	1.82B	1.38B	0.96B	2.18B	1.93B	1.43B	1.50B	2.92B	2.45B	2.54B	2.33B	3.08B
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)
Income from Continuing Operations (Quarter)	0.76B	-2.00B	-0.64B	0.55B	0.25B	0.92B	0.78B	2.26B	2.09B	1.65B	0.90B	2.80B	2.40B	1.83B	1.67B	3.40B	3.13B	3.24B	2.63B	3.91B
Consolidated Net Income (Quarter)	0.76B	-2.00B	-0.64B	0.55B	0.25B	0.92B	0.78B	2.26B	2.09B	1.65B	0.90B	2.80B	2.40B	1.83B	1.67B	3.40B	3.13B	3.24B	2.63B	3.91B
Income towards Parent Company (Quarter)	1.19B	-1.98B	-0.75B	0.41B	-0.37B	1.64B	1.71B	2.18B	1.82B	1.37B	1.78B	2.18B	1.93B	2.65B	1.50B	4.02B	3.56B	2.58B	2.77B	3.08B
Net Income towards Common Stockholders (Quarter)	1.19B	-1.98B	-0.75B	0.41B	-0.37B	1.64B	1.71B	2.18B	1.82B	1.37B	1.78B	2.18B	1.93B	2.65B	1.50B	4.02B	3.56B	2.58B	2.77B	3.08B
Additional items
EPS (Basic) (Quarter)	0.91	-5.12	-1.93	1.05	-0.96	4.24	4.42	0.00B	1.17	0.00B	4.59	0.00B	4.97	6.84	3.87	10.35	9.16	6.64	7.14	0.00B
EPS (Weighted Average and Diluted) (Quarter)	743.75
Shares Outstanding (Weighted Average) (Quarter)	1.31B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.00B	1.55B	0.00B	0.39B	0.00B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.39B	0.00B
Shares Outstanding (Diluted Average) (Quarter)	0.00B
EBITDA (Quarter)	1.19B	-1.98B	-0.75B	0.41B	-0.37B	0.67B	1.71B	2.18B	1.47B	1.26B	1.78B	1.76B	1.93B	2.66B	-0.11B	4.02B	3.56B	2.58B	2.78B	2.71B
Interest Expenses (Quarter)	-0.33B	-0.34B	-0.34B	-0.34B	-0.31B	-0.34B	-0.36B	-0.36B	-0.43B	-0.39B	-0.45B	-0.41B	-0.44B	-0.46B	-0.43B	-0.35B	-0.44B	-0.43B	-0.48B	-0.39B

Research Tools

Astrazeneca Income Statement (2009-2026) | AZN

Create an account

Sign In

Reset Password